|
ENST00000638012.2
|
ENST00000638012.2_1_28_+ |
1–28 |
439.00 |
16.71 |
1.28 |
100.0 |
MEG8-222
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000638012.2
|
ENST00000638012.2_1_70_+ |
1–70 |
490.00 |
18.65 |
1.43 |
100.0 |
MEG8-222
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_7388_7482_+ |
7388–7482 |
1062.00 |
8.54 |
3.10 |
97.97 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_4125_4215_+ |
4125–4215 |
6153.00 |
49.48 |
17.95 |
96.04 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_9465_9551_+ |
9465–9551 |
1041.00 |
8.37 |
3.04 |
100.0 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_5267_5357_+ |
5267–5357 |
1780.00 |
14.31 |
5.19 |
92.61 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_4125_4168_+ |
4125–4168 |
19.00 |
0.15 |
0.06 |
100.0 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_7389_7479_+ |
7389–7479 |
96.00 |
0.77 |
0.28 |
38.25 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_288_349_+ |
288–349 |
546.00 |
4.39 |
1.59 |
74.18 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000640631.2
|
ENST00000640631.2_287_352_+ |
287–352 |
426.00 |
3.43 |
1.24 |
65.74 |
SNHG14-224
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000648813.1
|
ENST00000648813.1_104_120_+ |
104–120 |
2743.60 |
13.33 |
8.00 |
53.59 |
5S_rRNA.20-201
|
rRNA pseudogene
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000649692.2
|
ENST00000649692.2_3826_3892_+ |
3826–3892 |
301.00 |
2.34 |
0.88 |
100.0 |
HSPA9-211
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000649692.2
|
ENST00000649692.2_1755_1822_+ |
1755–1822 |
5929.00 |
46.03 |
17.29 |
61.33 |
HSPA9-211
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650189.1
|
ENST00000650189.1_167_187_+ |
167–187 |
4461.00 |
30.61 |
13.01 |
100.0 |
DNM3OS-205
|
lncRNA
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1075_1108_+ |
1075–1108 |
212.00 |
0.02 |
0.62 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_2858_2910_+ |
2858–2910 |
1983.00 |
0.22 |
5.78 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_709_770_+ |
709–770 |
264.00 |
0.03 |
0.77 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1648_1723_+ |
1648–1723 |
456.00 |
0.05 |
1.33 |
86.53 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_137_198_+ |
137–198 |
3585.00 |
0.40 |
10.46 |
73.48 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1391_1418_+ |
1391–1418 |
12.00 |
0.00 |
0.04 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_2631_2663_+ |
2631–2663 |
810.00 |
0.09 |
2.36 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1048_1103_+ |
1048–1103 |
423.00 |
0.05 |
1.23 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1048_1108_+ |
1048–1108 |
494153.00 |
55.02 |
1441.45 |
99.88 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1424_1452_+ |
1424–1452 |
1749.00 |
0.19 |
5.10 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|
|
ENST00000650796.1
|
ENST00000650796.1_1048_1075_+ |
1048–1075 |
605.00 |
0.07 |
1.76 |
100.0 |
GAS5-230
|
retained intron
|
subcutaneous adipose tissue
(Tissue)
|